trending Market Intelligence /marketintelligence/en/news-insights/trending/gJd5K89hZ6pvph4it5BNGA2 content esgSubNav
In This List

Silk Road Medical shareholders price upsized secondary offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Silk Road Medical shareholders price upsized secondary offering

Silk Road Medical Inc. said certain shareholders priced their sale of 4.2 million common shares of the company at $39.50 per share.

The secondary offering was upsized from the previous offering size of 3.5 million common shares. The 30-day option for the underwriters to purchase additional shares was also upsized to 630,000 common shares from 525,000 common shares.

The offering is expected to close Aug. 13.

J.P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering, while BMO Capital Markets and Stifel are acting as co-managers.

Silk Road is a medical device company focused on reducing the risk of stroke.